Why the study?
Do quinapril and vitamin C reduce left ventricular hypertrophy and endothelial dysfunction in a guinea pig model of pressure overload?
Do quinapril and vitamin C reduce left ventricular hypertrophy and endothelial dysfunction in a guinea pig model of pressure overload?
Quinapril and vitamin C may inhibit pressure overload-induced left ventricular hypertrophy by reducing oxidative stress and improving endothelial function.
Remains preclinical only; leaves open translation of quinapril-vitamin C effects to human pressure-overload LVH.
Left ventricular hypertrophy (LVH) is a cardiovascular risk factor. A possible role for endothelial dysfunction in this condition was investigated in a Dunkin-Hartley guinea pig aortic-banded pressure overload-induced model of LVH. Aortic banding produced significant elevation of fore- and hindlimb blood pressure (BP), heart-to-body weight ratios, plasma angiotensin II (ANG II), endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-alpha) levels, and coronary microvascular endothelial cell (CMEC) NAD(P)H-dependent superoxide (O) production, and a significant decrease in basal and stimulated CMEC cGMP levels. Treatment of aortic-banded animals with the angiotensin-converting enzyme inhibitor quinapril and the antioxidant vitamin C, either alone or in combination, did not affect BP but caused a significant inhibition of the increases in the heart-to-body weight ratio, ANG II, ET-1, and TNF-alpha levels, and O production and restored cGMP responses to levels comparable with sham-operated animals. These data suggest that quinapril and vitamin C are capable of inhibiting LVH development due to pressure overload via mechanisms that involve the inhibition of oxidative stress, an improvement in coronary endothelial function, and increased nitric oxide bioavailability.
No takes yet. Share an insight, caveat, or question.
Bell et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: